載入...
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This...
Na minha lista:
| 發表在: | Hepatol Commun |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721453/ https://ncbi.nlm.nih.gov/pubmed/29404453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1036 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|